Comparing Interleukin 6 and Procalcitonin for Sepsis Detection in Burn Patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of Interleukin-6 (IL-6) compared to procalcitonin in identifying sepsis and septic shock in burn patients. Patients admitted to the burn ICU will have blood samples taken on days 1, 3, 7, and 10 to measure levels of IL-6 and procalcitonin. The results will guide clinical decisions regarding treatment success and the timing of ICU discharge. The study follows a structured treatment protocol based on the burn ICU standards.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with acute burn admitted to burn ICU within 24 hours from the burn incidence.
* patients with burn percentage of 25% to 50% of total body surface area
* patients with second to third degree burns
* ASA 1 and ASA 2 patients

Exclusion Criteria:

* Burn percentage more than 50% or less than 25% of total body surface area
* Having autoimmune diseases
* Cancer patients
* ASA 3 and ASA 4 patients

Where it's running

• Ain Shams University
  Cairo, Egypt Recruiting

Study contacts

• Principal investigator: Ahmed H Elsayed, M.B.B.CH — Anaesthesia, intensive care, and pain management resident Ain Shams University
• Study coordinator: Ahmed H Elsayed, M.B.B.CH
• Email: AhmedHanyAbdelfatah@med.asu.edu.eg
• Phone: +201016305451

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Registry for monitoring CytoSorb device use in critically ill patients

  This study is collecting information on how the CytoSorb device helps critically ill patients to improve care for conditions like septic shock and acute respiratory distress syndrome.

  Recruiting at 24 sites CytoSorbents, Inc · Klagenfurt and 27 other locations · NCT05146336

• Early detection of sepsis-related blood clotting problems in severe burn patients

  This study tests how well the JAAM-2 score can detect sepsis-induced coagulopathy early in adults with severe burns who develop sepsis in the ICU.

  Recruiting Center for Traumatology and Major Burns, Ben Arous · Tunis · NCT07914205

• Non-invasive hemodynamic guidance for sepsis care on medical wards

  This trial tests whether guiding fluid and vasopressor therapy for sepsis using non-invasive hemodynamic measurements works better than standard care.

  Recruiting at 2 sites Regione del Veneto - AULSS n. 7 Pedemontana · Pisa, Pisa and 1 other locations · NCT07863323

• Personalized Fluid Resuscitation in the Emergency Department

  This pilot test checks if a quick, non-invasive stroke-volume assessment can help ED doctors tailor IV fluids for septic patients with low blood pressure.

  Recruiting Intermountain Health Care, Inc. · Murray, Utah · NCT07779720

• Discordance between capillary refill time and oxygen use in septic shock

  This study tests whether some septic shock patients can have a normal capillary refill time but still lack tissue oxygen use, to see if that mismatch relates to 28-day survival.

  Recruiting Istanbul University - Cerrahpasa · Istanbul · NCT07774962

• Targeting upper-normal magnesium to see if norepinephrine needs drop in septic shock

  This trial tests whether keeping magnesium levels at the upper end of normal can reduce the amount and duration of norepinephrine needed in adults with septic shock.

  Recruiting Alexandria University · Alexandria, Alexandria Governorate · NCT07716956

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.